Actively Recruiting
Allogeneic Wharton Jelly Mesenchymal Stromal Cell (WJMSC) for Treatment of Autism
Led by University of Jordan · Updated on 2025-01-24
14
Participants Needed
1
Research Sites
299 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Autism spectrum disorders (ASDs) are characterized by core domains: persistent deficits in social communication and interaction; restricted, repetitive patterns of behavior, interests, or activities.
CONDITIONS
Official Title
Allogeneic Wharton Jelly Mesenchymal Stromal Cell (WJMSC) for Treatment of Autism
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Children aged 4 to 14 years
- Diagnosed with autism spectrum disorder (ASD)
- Able to follow the dosing and follow-up schedule
You will not qualify if you...
- Older than 14 years
- Weighing less than 10 kilograms
- History of severe allergy
- History of severe head trauma with loss of consciousness, hospitalization, skull fracture, or stroke
- Seizure within the past year or current/past use of seizure medications
- Severe, moderate, or uncontrolled systemic disease
- Unable to follow dosing and follow-up schedule
- Use of stimulant or non-stimulant ADHD medications within 7 days before study start
- Use of selective serotonin reuptake inhibitors (SSRIs) not stable for at least 30 days before study
- History of premature birth before 35 weeks gestation
- Prior stroke or other insult before birth
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Cell Therapy Center
Amman, Jordan, 00962
Actively Recruiting
Research Team
H
Hanan Jafar, PhD
CONTACT
A
Abdallah Awidi, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here